Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
Expert Opin Drug Saf. 2022 Aug;21(8):1089-1111. doi: 10.1080/14740338.2022.2106368. Epub 2022 Aug 30.
Antimicrobial resistance (AMR) is a concern as this increases morbidity, mortality, and costs, with sub-Saharan Africa having the highest rates globally. Concerns with rising AMR have resulted in international, Pan-African, and country activities including the development of national action plans (NAPs). However, there is variable implementation across Africa with key challenges persisting.
Consequently, there is an urgent need to document current NAP activities and challenges across sub-Saharan Africa to provide future guidance. This builds on a narrative review of the literature.
All surveyed sub-Saharan African countries have developed their NAPs; however, there is variable implementation. Countries including Botswana and Namibia are yet to officially launch their NAPs with Eswatini only recently launching its NAP. Cameroon is further ahead with its NAP than these countries; though there are concerns with implementation. South Africa appears to have made the greatest strides with implementing its NAP including regular monitoring of activities and instigation of antimicrobial stewardship programs. Key challenges remain across Africa. These include available personnel, expertise, capacity, and resources to undertake agreed NAP activities including active surveillance, lack of focal points to drive NAPs, and competing demands and priorities including among donors. These challenges are being addressed, with further co-ordinated efforts needed to reduce AMR.
抗生素耐药性(AMR)令人担忧,因为这会增加发病率、死亡率和治疗成本,而撒哈拉以南非洲的 AMR 发生率居全球之首。人们对 AMR 不断上升的担忧导致了包括制定国家行动计划(NAP)在内的国际、泛非和国家层面的活动。然而,非洲各地的执行情况存在差异,主要挑战仍然存在。
因此,迫切需要记录撒哈拉以南非洲目前的 NAP 活动和挑战,为未来提供指导。这是对文献进行叙述性综述的基础上进行的。
所有接受调查的撒哈拉以南非洲国家都制定了本国的 NAP,但执行情况存在差异。博茨瓦纳和纳米比亚等国尚未正式推出 NAP,而斯威士兰最近才推出 NAP。喀麦隆在执行 NAP 方面比这些国家更为超前;尽管对执行情况存在一些担忧。南非在实施其 NAP 方面似乎迈出了最大的步伐,包括定期监测活动和发起抗菌药物管理计划。非洲各地仍然存在关键挑战。这些挑战包括开展商定的 NAP 活动所需的人员、专业知识、能力和资源,包括主动监测、缺乏推动 NAP 的协调人,以及包括捐助方在内的相互竞争的需求和优先事项。这些挑战正在得到解决,需要进一步协调努力,以减少 AMR。